Evaluation of Sodium Pentaborate on Left Side Ulcerative Colitis
Phase 3
Recruiting
- Conditions
- lcerative Colitis.Ulcerative colitis
- Registration Number
- IRCT20190701044062N11
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
All left side ulcerative colitis patients who are between 18 and 65 years old
Exclusion Criteria
Patients who can't endure enema
Patients with other diseases as : Crohn's disease, Intermediate Colitis, CMV, Pseudomemberanous Colitis, Heart Failure, CRF, PSC
Pregnant or breastfeeding patients
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Activity of disease based on Mayo score. Timepoint: Assessment of disease activity at the beginning of the study and 28 days after the start of using Sodium Pentaborate enema. Method of measurement: Mayo Score.
- Secondary Outcome Measures
Name Time Method Frequency of daily defecation. Timepoint: Assessment of daily defecation frequency at the beginning of the study and 28 days after the start of using Sodium Pentaborate enema. Method of measurement: By asking the patient about frequency of daily defecation and using it in Mayo Score scale.;Rectal Bleeding. Timepoint: Assessment of rectal bleeding at the beginning of the study and 28 days after the start of using Sodium Pentaborate enema. Method of measurement: By asking the patient about frequency and amount of of rectal bleeding and using it in Mayo Score scale.;Endoscopic findings. Timepoint: Assessment of endoscopic findings at the beginning of the study and 28 days after the start of using Sodium Pentaborate enema. Method of measurement: By direct vision of endoscopist based on Endoscopic Sub Score in Mayo Score scale.